396
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Molecular Epidemiology of Community-Acquired Methicillin-Resistant Staphylococcus aureus and Clinical Characteristics of Different Sites of Infection

, ORCID Icon, , , , & show all
Pages 1485-1497 | Received 29 Dec 2022, Accepted 09 Feb 2023, Published online: 15 Mar 2023

References

  • Jenkins A, Diep BA, Mai TT, et al. Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease. mBio. 2015;6(1):e02272–14. doi:10.1128/mBio.02272-14
  • Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 2001;32:S114–S132. doi:10.1086/320184
  • DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 2009;119(9):2464–2474. doi:10.1172/JCI38226
  • Kirby WM. Extraction of a highly potent penicillin inactivator from penicillin resistant Staphylococci. Science. 1944;99(2579):452–453. doi:10.1126/science.99.2579.452
  • David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616–687. doi:10.1128/CMR.00081-09
  • DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557–1568. doi:10.1016/S0140-6736(09)61999-1
  • Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8):593–598. doi:10.1001/jama.279.8.593
  • Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40(1):100–107. doi:10.1086/427148
  • Mandell LA, Wunderink R. Methicillin-resistant Staphylococcus aureus and community-acquired pneumonia: an evolving relationship. Clin Infect Dis. 2012;54(8):1134–1136. doi:10.1093/cid/cis045
  • American Thoracic S; Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. doi:10.1164/rccm.200405-644ST
  • Boye K, Bartels MD, Andersen IS, Moller JA, Westh H. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin Microbiol Infect. 2007;13(7):725–727. doi:10.1111/j.1469-0691.2007.01720.x
  • Funaki T, Yasuhara T, Kugawa S, et al. SCCmec typing of PVL-positive community-acquired Staphylococcus aureus (CA-MRSA) at a Japanese hospital. Heliyon. 2019;5(3):e01415. doi:10.1016/j.heliyon.2019.e01415
  • Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JA, Kreiswirth BN. spa Typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol. 2004;42(2):792–799. doi:10.1128/Jcm.42.2.792-799.2004
  • Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: bIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124. doi:10.12688/wellcomeopenres.14826.1
  • Johnsson D, Molling P, Stralin K, Soderquist B. Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. Clin Microbiol Infect. 2004;10(10):884–889. doi:10.1111/j.1469-0691.2004.00976.x
  • Indrawattana N, Sungkhachat O, Sookrung N, et al. Staphylococcus aureus clinical isolates: antibiotic susceptibility, molecular characteristics, and ability to form biofilm. Biomed Res Int. 2013;2013:314654. doi:10.1155/2013/314654
  • Gowrishankar S, Kamaladevi A, Balamurugan K, Pandian SK. In vitro and in vivo biofilm characterization of methicillin-resistant Staphylococcus aureus from patients associated with pharyngitis infection. Biomed Res Int. 2016;2016:1289157. doi:10.1155/2016/1289157
  • Strommenger B, Kettlitz C, Weniger T, Harmsen D, Friedrich AW, Witte W. Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol. 2006;44(7):2533–2540. doi:10.1128/JCM.00420-06
  • Cheng J, Wang Y, Cao Y, et al. The distribution of 18 enterotoxin and enterotoxin-like genes in Staphylococcus aureus strains from different sources in East China. Foodborne Pathog Dis. 2016;13(4):171–176. doi:10.1089/fpd.2015.1963
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twentieth Informational Supplement. Clinical and Laboratory Standards Institute; 2010. Available from: https://clsi.org/. Accessed May 6, 2019.
  • Chuang YY, Huang YC. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis. 2013;13(8):698–708. doi:10.1016/S1473-3099(13)70136-1
  • Geng W, Yang Y, Wu D, et al. Community-acquired, methicillin-resistant Staphylococcus aureus isolated from children with community-onset pneumonia in China. Pediatr Pulmonol. 2010;45(4):387–394. doi:10.1002/ppul.21202
  • Wang B, Xu Y, Zhao H, et al. Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing. Emerg Microbes Infect. 2022;11(1):532–542. doi:10.1080/22221751.2022.2032373
  • Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9(8):978–984. doi:10.3201/eid0908.030089
  • Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intens Care Med. 2003;29(10):1840–1843. doi:10.1007/s00134-003-1918-5
  • Montgomery CP, Daum RS. Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin? Infect Immun. May. 2009;77(5):2159–2167. doi:10.1128/IAI.00021-09
  • Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med. 2007;13(12):1405–1406. doi:10.1038/nm1207-1405
  • Zhou Y, Niu C, Ma B, et al. Inhibiting PSMalpha-induced neutrophil necroptosis protects mice with MRSA pneumonia by blocking the agr system. Cell Death Dis. 2018;9(3):362. doi:10.1038/s41419-018-0398-z
  • Cassat JE, Hammer ND, Campbell JP, et al. A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe. 2013;13(6):759–772. doi:10.1016/j.chom.2013.05.003
  • Zarei Koosha R, Mahmoodzadeh Hosseini H, Mehdizadeh Aghdam E, Ghorbani Tajandareh S, Imani Fooladi AA. Distribution of TSST-1 and mecA genes in Staphylococcus aureus isolated from clinical specimens. Jundishapur J Microbiol. 2016;9(3):e29057. doi:10.5812/jjm.29057
  • Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep. 2007;33(4):45–48.
  • Wang J, Yun L, Zhao H, Li X. Combination therapy of polymyxin B and amikacin for community-acquired pseudomonas aeruginosa pneumonia with MODS in a Previously Healthy Patient: A Case Report. Infect Drug Resist. 2021;14:2895–2900. doi:10.2147/IDR.S312601
  • Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis. 2016;63(3):300–309. doi:10.1093/cid/ciw300
  • Buck JM, Como-Sabetti K, Harriman KH, et al. Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003. Emerg Infect Dis. 2005;11(10):1532–1538. doi:10.3201/eid1110.050141
  • Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51(3):291–298. doi:10.1016/j.annemergmed.2007.12.004
  • Olaniyi R, Pozzi C, Grimaldi L, Bagnoli F. Staphylococcus aureus-associated skin and soft tissue infections: anatomical localization, epidemiology, therapy and potential prophylaxis. Curr Top Microbiol Immunol. 2017;409:199–227. doi:10.1007/82_2016_32
  • Maor Y, Belausov N, Ben-David D, Smollan G, Keller N, Rahav G. hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre. Clin Microbiol Infect. 2014;20(10):O730–6. doi:10.1111/1469-0691.12498
  • Xing L, Chen Y, Ling X, et al. Genomic characterization of livestock-associated methicillin-resistant Staphylococcus aureus ST7 Isolates from a case of human bacteremia in China. Infect Drug Resist. 2022;15:7449–7457. doi:10.2147/IDR.S385061
  • Millar BC, Prendergast BD, Moore JE, Community-associated MRSA. CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother. 2008;61(1):1–7. doi:10.1093/jac/dkm410
  • Tsouklidis N, Kumar R, Heindl SE, Soni R, Khan S. Understanding the fight against resistance: hospital-acquired methicillin-resistant Staphylococcus aureus vs community-acquired methicillin-resistant Staphylococcus aureus. Cureus. 2020;12(6):e8867. doi:10.7759/cureus.8867
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–S72. doi:10.1086/511159
  • Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012;54(5):621–629. doi:10.1093/cid/cir895
  • Yeager SD, Oliver JE, Shorman MA, Wright LR, Veve MP. Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections. Int J Antimicrob Agents. 2021;57(5):106329. doi:10.1016/j.ijantimicag.2021.106329
  • Kato H, Hagihara M, Asai N, et al. Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus. J Glob Antimicrob Resist. 2021;24:98–105. doi:10.1016/j.jgar.2020.12.009
  • Sabol KE, Echevarria KL, Lewis JS. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs. Ann Pharmacother. 2006;40(6):1125–1133. doi:10.1345/aph.1G404
  • Pallin DJ, Binder WD, Allen MB, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis. 2013;56(12):1754–1762. doi:10.1093/cid/cit122
  • Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):S378–S385. doi:10.1086/533594